Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 10.06%25.25B | ---- | 11.45%22.95B | ---- | 14.84%20.59B | ---- | 11.85%17.93B | ---- | 13.13%16.03B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 5.89%-1.98B | ---- | -20.49%-2.11B | ---- | -43.79%-1.75B | ---- | 11.05%-1.22B | ---- | -7.39%-1.37B |
| Dividend (income)- adjustment | ---- | 1.89%-156M | ---- | -6.71%-159M | ---- | 16.76%-149M | ---- | 14.76%-179M | ---- | -2.44%-210M |
| Investment loss (gain) | ---- | 3.77%-408M | ---- | 3.20%-424M | ---- | 48.47%-438M | ---- | -388.51%-850M | ---- | ---174M |
| Attributable subsidiary (profit) loss | ---- | 5.76%-4.07B | ---- | -15.38%-4.32B | ---- | -13.17%-3.75B | ---- | -39.37%-3.31B | ---- | -18.45%-2.38B |
| Impairment and provisions: | ---- | 14.46%7.28B | ---- | -8.12%6.36B | ---- | 109.57%6.92B | ---- | -40.88%3.3B | ---- | 52.44%5.58B |
| -Impairmen of inventory (reversal) | ---- | 14.46%7.28B | ---- | -8.12%6.36B | ---- | 109.57%6.92B | ---- | -40.88%3.3B | ---- | 52.44%5.58B |
| Revaluation surplus: | ---- | 49.14%-59M | ---- | -383.33%-116M | ---- | -161.54%-24M | ---- | 125.32%39M | ---- | -60.42%-154M |
| -Other fair value changes | ---- | 49.14%-59M | ---- | -383.33%-116M | ---- | -161.54%-24M | ---- | 125.32%39M | ---- | -60.42%-154M |
| Asset sale loss (gain): | ---- | -344.00%-2.85B | ---- | -35.58%1.17B | ---- | -51.53%1.81B | ---- | 63.92%3.73B | ---- | 5.71%2.28B |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | -49.80%1.88B | ---- | 58.52%3.75B | ---- | 8.54%2.37B |
| -Loss (gain) from selling other assets | ---- | -344.00%-2.85B | ---- | 1,719.44%1.17B | ---- | -380.00%-72M | ---- | 82.76%-15M | ---- | -262.50%-87M |
| Depreciation and amortization: | ---- | -1.71%83.39B | ---- | -2.28%84.85B | ---- | 1.37%86.83B | ---- | 3.17%85.65B | ---- | -0.08%83.02B |
| -Depreciation | ---- | -1.71%83.39B | ---- | -2.28%84.85B | ---- | 1.37%86.83B | ---- | 3.17%85.65B | ---- | -0.08%83.02B |
| Financial expense | ---- | -11.40%1.73B | ---- | 87.00%1.96B | ---- | -20.03%1.05B | ---- | -16.37%1.31B | ---- | -21.45%1.56B |
| Special items | ---- | -12.41%247M | ---- | 412.73%282M | ---- | -59.56%55M | ---- | -63.73%136M | ---- | -34.33%375M |
| Operating profit before the change of operating capital | ---- | -1.85%108.38B | ---- | -0.64%110.43B | ---- | 4.32%111.14B | ---- | 1.89%106.54B | ---- | 2.47%104.57B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -301.06%-377M | ---- | 72.19%-94M | ---- | 5.85%-338M | ---- | -708.47%-359M | ---- | 117.61%59M |
| Accounts receivable (increase)decrease | ---- | -61.47%-30.13B | ---- | -36.60%-18.66B | ---- | -210.08%-13.66B | ---- | 0.07%-4.41B | ---- | 8.64%-4.41B |
| Accounts payable increase (decrease) | ---- | 26.58%24.93B | ---- | 20.65%19.7B | ---- | 34.09%16.33B | ---- | 29.63%12.18B | ---- | 217.94%9.39B |
| Advance payment increase (decrease) | ---- | 24.00%-76M | ---- | -137.59%-100M | ---- | 218.22%266M | ---- | -875.86%-225M | ---- | 1,350.00%29M |
| prepayments (increase)decrease | ---- | -570.47%-1.29B | ---- | 94.66%-193M | ---- | -106.70%-3.61B | ---- | 58.19%-1.75B | ---- | -122.71%-4.18B |
| Special items for working capital changes | ---- | -33.50%-7.43B | ---- | 25.77%-5.57B | ---- | -373.72%-7.5B | ---- | 292.55%2.74B | ---- | 119.18%698M |
| Cash from business operations | -3.38%32.15B | -10.93%94.44B | -19.37%33.27B | 2.57%106.02B | -6.16%41.27B | -9.66%103.37B | -17.64%43.98B | 6.50%114.41B | 10.62%53.39B | 13.14%107.43B |
| Other taxs | 21.03%-3.15B | -44.25%-4.78B | -33.64%-3.99B | -23.56%-3.32B | -65.12%-2.98B | 32.52%-2.68B | 33.85%-1.81B | -4,690.36%-3.98B | -427.03%-2.73B | -126.02%-83M |
| Interest received - operating | ---- | -5.89%1.98B | ---- | 20.49%2.11B | ---- | 43.79%1.75B | ---- | -7.18%1.22B | ---- | -15.60%1.31B |
| Interest paid - operating | ---- | 5.72%-1.8B | ---- | -65.74%-1.91B | ---- | 13.14%-1.15B | ---- | 27.73%-1.32B | ---- | 27.33%-1.83B |
| Special items of business | ---- | 15.53%-435M | ---- | 30.59%-515M | ---- | -341.69%-742M | ---- | 124.15%307M | ---- | -104.01%-1.27B |
| Net cash from operations | -0.98%29B | -12.69%89.4B | -23.50%29.29B | 1.84%102.39B | -9.21%38.29B | -9.13%100.54B | -16.76%42.17B | 4.82%110.64B | 6.10%50.66B | 12.67%105.55B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | 47.14%2.29B | ---- | 19.89%1.56B | ---- | 59.53%1.3B | ---- | 7.54%813M | ---- | 163.41%756M |
| Loan receivable (increase) decrease | ---- | ---400M | ---- | --0 | ---- | 5,700.00%5.8B | ---- | 103.58%100M | ---- | -832.00%-2.8B |
| Decrease in deposits (increase) | ---- | -1,722.39%-29.2B | ---- | 171.49%1.8B | ---- | -529.50%-2.52B | ---- | 94.20%-400M | ---- | -20,394.12%-6.9B |
| Sale of fixed assets | ---- | 42.36%1.98B | ---- | -18.83%1.39B | ---- | -24.57%1.71B | ---- | 37.64%2.27B | ---- | 8.93%1.65B |
| Purchase of fixed assets | 6.76%-29.92B | 4.58%-75.74B | 3.41%-32.08B | -9.53%-79.38B | -7.14%-33.22B | -0.59%-72.47B | -1.24%-31B | -22.83%-72.05B | -20.77%-30.62B | -4.39%-58.66B |
| Sale of subsidiaries | ---- | ---- | ---- | --400M | ---- | ---- | ---- | -57.89%8M | ---- | --19M |
| Acquisition of subsidiaries | ---- | 80.03%-156M | ---- | -78,000.00%-781M | ---- | 99.96%-1M | ---- | -61.87%-2.37B | ---- | -864.47%-1.47B |
| Recovery of cash from investments | ---- | 23.78%23.65B | ---- | -33.53%19.1B | ---- | -67.37%28.74B | ---- | 168.30%88.08B | ---- | 6,082.49%32.83B |
| Cash on investment | ---- | 70.75%-7.08B | ---- | -24.98%-24.21B | ---- | 79.10%-19.37B | ---- | -61.35%-92.7B | ---- | -13,481.80%-57.45B |
| Other items in the investment business | -79.15%1.95B | 100.28%15M | 557.58%9.33B | -874.86%-5.42B | -115.74%-2.04B | -52.12%700M | 618.49%12.96B | --1.46B | 87.39%-2.5B | ---- |
| Net cash from investment operations | -22.93%-27.97B | 1.04%-84.66B | 35.46%-22.75B | -52.45%-85.54B | -95.37%-35.26B | 24.97%-56.11B | 45.51%-18.05B | 18.73%-74.78B | 26.69%-33.12B | -55.82%-92.02B |
| Net cash before financing | -84.22%1.03B | -71.83%4.75B | 115.68%6.54B | -62.08%16.85B | -87.44%3.03B | 23.91%44.43B | 37.52%24.13B | 164.92%35.85B | 582.34%17.54B | -60.92%13.53B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 15.38%1.49B | ---- | 61.55%1.29B | ---- | -10.20%801M | ---- | -67.45%892M | ---- | -90.50%2.74B |
| Refund | ---- | 44.33%-1.13B | ---- | -153.04%-2.04B | ---- | 79.93%-805M | ---- | 49.93%-4.01B | ---- | 79.33%-8.01B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | -26.47%5B | ---- | -15.00%6.8B | ---- | -33.26%8B |
| Dividends paid - financing | -482.80%-4.78B | -22.39%-11.68B | -22.57%-820M | -19.53%-9.55B | 77.22%-669M | 8.10%-7.99B | 41.47%-2.94B | -59.54%-8.69B | 7.88%-5.02B | -32.85%-5.45B |
| Absorb investment income | ---- | -94.30%22M | ---- | -55.48%386M | ---- | 8,570.00%867M | ---- | -84.85%10M | ---- | -87.01%66M |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | 49.01%-5B | ---- | -22.49%-9.81B | ---- | 20.01%-8.01B | ---- | 41.14%-10.01B |
| Other items of the financing business | 240.44%1.8B | -94.98%125M | -320.10%-1.28B | 67.07%2.49B | 112.30%582M | 29.54%1.49B | 35.86%-4.73B | 234.31%1.15B | -1,203.53%-7.38B | -645.22%-857M |
| Net cash from financing operations | -12.55%-9.51B | 1.84%-24.06B | -36.85%-8.45B | -2.96%-24.52B | 55.74%-6.18B | 3.13%-23.81B | 22.90%-13.95B | 2.50%-24.58B | -61.99%-18.1B | 15.30%-25.21B |
| Effect of rate | 39.13%32M | -36.89%65M | -88.73%23M | -74.38%103M | -4.67%204M | 615.38%402M | 694.44%214M | 57.38%-78M | -340.00%-36M | -832.00%-183M |
| Net Cash | -342.46%-8.48B | -151.96%-19.32B | 39.07%-1.92B | -137.19%-7.67B | -130.93%-3.15B | 82.87%20.62B | 1,932.61%10.17B | 196.54%11.27B | 93.55%-555M | -340.27%-11.68B |
| Begining period cash | -40.33%28.48B | -13.68%47.73B | -13.68%47.73B | 61.31%55.3B | 61.31%55.3B | 48.49%34.28B | 48.49%34.28B | -33.94%23.09B | -33.94%23.09B | 16.25%34.95B |
| Cash at the end | -56.30%20.03B | -40.33%28.48B | -12.45%45.84B | -13.68%47.73B | 17.22%52.36B | 61.31%55.3B | 98.56%44.67B | 48.49%34.28B | -14.66%22.49B | -33.94%23.09B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants, Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.